Showing results (401-410 of 462) with videos related to

Sort By:
Pageof 47
Pharmacology & Therapeutics|January 31, 2017
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injuryDaniel F Carr, Seyoum Ayehunie, Andrea Davies, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.
Frontiers in Immunology|May 21, 2021
HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai PatientsPatompong Satapornpong, Jirawat Pratoomwun, Pawinee Rerknimitr, et al.
British Journal of Clinical Pharmacology|December 3, 2025
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, et al.
Pharmacogenomics|July 7, 2010
A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivativesTalitha I Verhoef, William K Redekop, Josep Darba, et al.
British Journal of Clinical Pharmacology|July 2, 2026
UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Dharmisha Chauhan, Cinzia Dello Russo, Jack Thompson, et al.
Gastroenterology|January 22, 2019
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver InjuryElizabeth T Cirulli, Paola Nicoletti, Karen Abramson, et al.
Blood|March 6, 2010
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groupsNita A Limdi, Mia Wadelius, Larisa Cavallari, et al.
Pageof 47